# Vaidya Sane Ayu (NSE: MADHAVBAUG) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MADHAVBAUG · Pivot · prices to 16 Oct 2026

Vaidya Sane Ayu (NSE: MADHAVBAUG) closed at ₹161.10 on 16 Oct 2026. With a market capitalisation of ₹169 Cr, it ranks 2374th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector.

Its return on equity was 12.5% in FY26. Over the past year the share price has fallen 43.1%. Its 52-week range is ₹147.00 (8 Sep 2026) to ₹335.00 (26 Dec 2025); the last close is 51.9% below the high. Promoters held 66.34% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹161.10 |
| Market cap | ₹169 Cr |
| ROE | 12.5% (FY26) |
| ROCE | 12.5% (FY26) |
| Debt to equity | 0.04 |
| 52-week high | ₹335.00 (26 Dec 2025) |
| 52-week low | ₹147.00 (8 Sep 2026) |
| 1-year return | −43.1% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹107 Cr | ₹9 Cr |
| FY25 | ₹90 Cr | ₹7 Cr |
| FY24 | ₹99 Cr | ₹2 Cr |
| FY23 | ₹99 Cr | ₹5 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 66.34%
- Non-institutions: 33.66%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Novelix Pharma](https://app.pivotnow.in/stock/NOVELIX) | — | ₹181 Cr | — | — |
| [Bal Pharma](https://app.pivotnow.in/stock/BALPHARMA) | ₹109.58 | ₹174 Cr | 27.7 | — |
| [Medico Remedies](https://app.pivotnow.in/stock/MEDICO) | ₹20.77 | ₹172 Cr | 13.1 | — |
| [Take Solutions](https://app.pivotnow.in/stock/TAKE) | ₹11.54 | ₹171 Cr | 39.8 | — |
| [Natural Capsules](https://app.pivotnow.in/stock/NATCAPSUQ) | ₹154.84 | ₹161 Cr | — | — |
| [Panchsheel Org](https://app.pivotnow.in/stock/PANCHSHEEL) | — | ₹159 Cr | — | — |

## Questions and answers

### What is the share price of Vaidya Sane Ayu today?

Vaidya Sane Ayu (NSE: MADHAVBAUG) last closed at ₹161.10 on 16 Oct 2026. Its 52-week high is ₹335.00 and its 52-week low is ₹147.00.

### What is the market cap of Vaidya Sane Ayu?

Vaidya Sane Ayu's market capitalisation is ₹169 Cr (₹169 Cr) at the 21 Oct 2026 close, ranking 2374th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Vaidya Sane Ayu?

Return on equity was 12.5% in FY26 and return on capital employed was 12.5% in FY26 (consolidated figures).

### Is Vaidya Sane Ayu a debt-free company?

Vaidya Sane Ayu is close to debt-free: its debt-to-equity ratio was 0.04 in FY26.

### How has Vaidya Sane Ayu stock performed over the last year?

Vaidya Sane Ayu's share price has fallen 43.1% over the past year, −7.9% over three months and +1.4% over one month, to the 21 Oct 2026 close.

### What is the shareholding pattern of Vaidya Sane Ayu?

As of 31 Mar 2026: promoters 66.34%, non-institutions 33.66%.

### Who are Vaidya Sane Ayu's competitors?

The listed Pharma & Healthcare companies closest to Vaidya Sane Ayu by market cap are Novelix Pharma, Bal Pharma, Medico Remedies, Take Solutions, Natural Capsules and Panchsheel Org.

### Is Vaidya Sane Ayu a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Vaidya Sane Ayu's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MADHAVBAUG against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.